The global seasonal affective disorder therapeutics market is estimated to witness potential growth during the forecast period. The major factors contributing to the growth of the market include the rising awareness regarding mental health and rising prevalence of seasonal affective disorder and depression. Rising insurance claims for mental health has shown emerging awareness regarding mental health. As per the Association of British Insurers (ABI), in 2017, mental health was the most common cause of claim on income protection policies in the UK. As a result, the ABI engage with the health and protection industry and charities to promote remarkable access to insurance for individuals suffering from mental health conditions.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/seasonal-affective-disorder-therapeutics-market
Emerging nations have also been started emphasizing on mental health owing to the increasing suicide rates. For instance, in India, the Insurance Regulatory and Development Authority of India (IRDAI) has directed the insurers to offer medical insurance to cover mental illness treatments. According to Sec 21(4) of the Mental Healthcare Act, 2017, every medical insurer will offer coverage to treat mental illness the same as available for the treatment of physical illness. In May 2018, this mental healthcare act 2017 came into appearance. These kinds of initiatives are supporting to increase awareness among people regarding mental health, which in turn, increases the demand for seasonal affective disorder treatment.
Browse for Full Report [email protected]
The seasonal affective disorder is a mental health condition caused by the changing in seasons. It is a subtype of bipolar disorder and unipolar or major depressive disorder. People suffering from the seasonal affective disorder have signs and symptoms of either bipolar disorder or unipolar disorder only during certain months of the year. Unipolar disorder is more common compared to bipolar disorder among people suffering from the seasonal affective disorder. This condition normally starts in a person's twenties or thirties. Medications and light therapy are used for the treatment of the condition.
Global Seasonal Affective Disorder Therapeutics Market by Disorder Type
• Unipolar Disorder
• Bipolar Disorder
Global Seasonal Affective Disorder Therapeutics Market by Treatment Type
• Selective Serotonin Reuptake Inhibitors (SSRIs)
• Monoamine Oxidase Inhibitors (MAOIs)
• Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)
• United States
• Rest of Europe
• Rest of Asia-Pacific
Rest of the World
• AbbVie Inc.
• Active Wearables GmbH
• Aura Day Light
• Bristol-Myers Squibb Co.
• Carex Health Brands
• Eli Lilly & Co.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• H. Lundbeck A/S
• Koninklijke Philips N.V.
• Lucimed SA
• Mylan N.V.
• Novalogy, Inc.
• Novartis International AG
• Otsuka Pharmaceutical Co., Ltd.
• Pfizer Inc.
• Shine-Mart Ltd. (Duronic)
• Teva Pharmaceutical Industries Ltd.
• Verilux, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/seasonal-affective-disorder-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404